Complications of anaesthesia during pregnancy. Other complications of anaesthesia during pregnancy
Conditions
Interventions
Intervention 1: Ringer's lactate (RL) solution (15 ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + mid thigh-high lower extremities bandage was performe
Prevention
Ringer's lactate (RL) solution (15 ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + mid thigh-high lower extremities bandage was performed immediately af
Colloid solution (Hemaxel) (7ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + mid thigh-high lower extremities bandage was performed immediately after spi
Ephedrine (15 mg, IV, bolus) was infused in 45 seconds. Duration of treatment: single dose Immediately after spinal injection+ mid thigh-high lower extremities bandage was performed immediately after
Ringer's lactate (RL) solution (15 ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + colloid solution (Hemaxel) (7ml/kg) was infused. Duration of treatment
Ringer's lactate (RL) solution (15 ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + Ephedrine (15 mg, IV, bolus) was infused in 45 seconds. Duration of tr
Colloid solution (Hemaxel) (7ml/kg) was infused. Duration of treatment: single dose in 30 minutes before spinal injection + Ephedrine (15 mg, IV, bolus) was infused in 45 seconds. Duration of treatmen
Sponsors
Vice chancellor for research- Isfahan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Parturients; ASA physical status I-II; scheduled for elective cesarean section; under spinal anesthesia; Exclusion Criteria: suspicious to bleeding disturbances; atopia; diabetes mellitus; presence of liver or kidney diseases; drugs abuse; hypertension of pregnancy; preeclampsia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure. Timepoint: On arrival to operating room, immediately after anesthesia (time 0), and minutes 3, 5, 15, 20, 25, 30, 35, and 60 after spinal injection. Method of measurement: Using mercury manometer.;Heart rate. Timepoint: On arrival to operating room, immediately after anesthesia (time 0), and minutes 3, 5, 15, 20, 25, 30, 35, and 60 after spinal injection. Method of measurement: Using EKG Monitoring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Apgar score. Timepoint: at min 1 and 5. Method of measurement: Apgar score mesurements by physical examination.;NACS. Timepoint: at 15 minutes, 2 hours, and 24 hours after delivery. Method of measurement: NACS mesurements by physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mitra Jabalameli
Isfahan University of Medical Sciences
Outcome results
None listed